Protective Efficacy of CAP18106-138-Immunoglobulin G in Sepsis

15Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Naturally present antibacterial proteins play an important role in innate host defense. A synthetic peptide mimicking the C-terminal lipopolysaccharide (LPS)-binding domain of rabbit cathelicidin CAP18 was coupled to immunoglobulin (Ig) G to create CAP18106-138-IgG, a construct that, in concentrations equimolar to those of peptide alone, binds and neutralizes LPS and kills multiple gram-negative bacterial strains. The protective efficacy of CAP18106-138-IgG was evaluated in a model of cecal ligation and puncture in mice. A single intravenous administration of 20 mg/kg CAP18 106-138-IgG protected against mortality, compared with sham-coupled IgG (P

Cite

CITATION STYLE

APA

Warren, H. S., Matyal, R., Allaire, J. E., Yarmush, D., Loiselle, P., Hellman, J., … Fink, M. P. (2003). Protective Efficacy of CAP18106-138-Immunoglobulin G in Sepsis. Journal of Infectious Diseases, 188(9), 1382–1393. https://doi.org/10.1086/379081

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free